{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:35:21Z","timestamp":1777365321523,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["2P01AG027296-11"],"award-info":[{"award-number":["2P01AG027296-11"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jamda.2024.105480","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:42:46Z","timestamp":1738942966000},"page":"105480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Visitation Restriction on Antipsychotic Drug Use among Nursing Home Residents with ADRD during the COVID-19 Pandemic"],"prefix":"10.1016","volume":"26","author":[{"given":"Tingting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Santostefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette B.","family":"Coe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren B.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie P.W.","family":"Bynum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-8783","authenticated-orcid":false,"given":"Theresa I.","family":"Shireman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105480_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105480_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer's disease: systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jamda.2024.105480_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2190\/ABXK-FMWG-98YP-D1CU","article-title":"The consequences of non-cognitive symptoms of dementia in medical hospital departments","volume":"33","author":"Wancata","year":"2003","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.jamda.2024.105480_bib4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1212\/01.WNL.0000036904.73393.E4","article-title":"The incremental direct costs associated with behavioral symptoms in AD","volume":"59","author":"Murman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2024.105480_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1046\/j.1532-5415.2003.51415.x","article-title":"Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioral symptoms associated with dementia","volume":"51","author":"American Geriatrics","year":"2003","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105480_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the Centers for Medicare & Medicaid Services' national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2024.105480_bib7","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2024.105480_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.jamda.2024.105480_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e977","article-title":"Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study","volume":"344","author":"Huybrechts","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2024.105480_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","article-title":"Risk of mortality among individual antipsychotics in patients with dementia","volume":"169","author":"Kales","year":"2012","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.jamda.2024.105480_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076268","article-title":"Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study","volume":"385","author":"Mok","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2024.105480_bib12","series-title":"State data and policy actions to Address Coronavirus","year":"2020"},{"key":"10.1016\/j.jamda.2024.105480_bib13","series-title":"Over 200,000 residents and staff in long-term care facilities have died from COVID-19","author":"Chidambaram","year":"2022"},{"key":"10.1016\/j.jamda.2024.105480_bib14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jgs.17161","article-title":"Changes in medication use among long-stay residents with dementia in Michigan during the pandemic","volume":"69","author":"Gerlach","year":"2021","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105480_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jgs.18116","article-title":"Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID-19","volume":"71","author":"Coe","year":"2022","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105480_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jagp.2022.09.009","article-title":"Did the COVID-19 pandemic affect the use of antipsychotics among nursing home residents with ADRD?","volume":"31","author":"Yan","year":"2023","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105480_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5878","article-title":"Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings","volume":"38","author":"McDermid","year":"2023","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105480_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamainternmed.2021.0224","article-title":"Assessment of psychotropic drug prescribing among nursing home residents in Ontario, Canada, during the COVID-19 pandemic","volume":"181","author":"Stall","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2024.105480_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18441","article-title":"Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada","volume":"4","author":"Campitelli","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2024.105480_bib20","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/alz.12143","article-title":"Tackling challenges in care of Alzheimer\u2019s disease and other dementias amid the COVID-19 pandemic, now and in the future","volume":"16","author":"Mok","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2024.105480_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.585540","article-title":"The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: a review","volume":"11","author":"Manca","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jamda.2024.105480_bib22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jagp.2020.04.010","article-title":"Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer\u2019s disease and related dementias","volume":"28","author":"Brown","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105480_bib23","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1111\/jgs.17947","article-title":"Benzodiazepine and antipsychotic use among hospitalized older adults before versus after restricting visitation. March to May 2020","volume":"70","author":"Brown","year":"2022","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105480_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/geront\/30.3.293","article-title":"Designing the national resident assessment instrument for nursing homes","volume":"30","author":"Morris","year":"1990","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2024.105480_bib28","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/gerona\/glab377","article-title":"Identification of dementia in recent Medicare claims data, compared to rigorous clinical assessments","volume":"77","author":"Grodstein","year":"2021","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2024.105480_bib29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/gerona\/glab373","article-title":"Validation of claims algorithms to identify Alzheimer\u2019s disease and related dementias","volume":"77","author":"McCarthy","year":"2022","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2024.105480_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"key":"10.1016\/j.jamda.2024.105480_bib31","series-title":"Stata Statistical Software: Release 17","year":"2021"},{"key":"10.1016\/j.jamda.2024.105480_bib32","series-title":"IBM SPSS Statistics for Windows, Version 28.0","year":"2021"},{"key":"10.1016\/j.jamda.2024.105480_bib33","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1016\/S2666-7568(23)00105-8","article-title":"Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK","volume":"4","author":"Schnier","year":"2023","journal-title":"Lancet Health Longev"},{"key":"10.1016\/j.jamda.2024.105480_bib34","series-title":"COVID-19 death rates in urban and rural areas: United States, 2020. NCHS Data Brief, no 447","author":"Curtin","year":"2022"},{"key":"10.1016\/j.jamda.2024.105480_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024009034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024009034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:35:49Z","timestamp":1777361749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024009034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1525861024009034"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105480","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Visitation Restriction on Antipsychotic Drug Use among Nursing Home Residents with ADRD during the COVID-19 Pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105480"}}